BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21910977)

  • 1. Urinary rubidium in breast cancers.
    Su Y; Chen LJ; He JR; Yuan XJ; Cen YL; Su FX; Tang LY; Zhang AH; Chen WQ; Lin Y; Wang SM; Ren ZF
    Clin Chim Acta; 2011 Nov; 412(23-24):2305-9. PubMed ID: 21910977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary strontium and the risk of breast cancer: a case-control study in Guangzhou, China.
    Chen LJ; Tang LY; He JR; Su Y; Cen YL; Yu DD; Wu BH; Lin Y; Chen WQ; Song EW; Ren ZF
    Environ Res; 2012 Jan; 112():212-7. PubMed ID: 22172139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary titanium and vanadium and breast cancer: a case-control study.
    Tang LY; Su Y; He JR; Chen WQ; Su FX; Wu BH; Lin Y; Ren ZF
    Nutr Cancer; 2012 Apr; 64(3):368-76. PubMed ID: 22332886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of urinary cesium with breast cancer risk.
    Qin YC; Tang LY; Su Y; Chen LJ; Su FX; Lin Y; Zhang AH; Ren ZF
    Asian Pac J Cancer Prev; 2014; 15(22):9785-90. PubMed ID: 25520105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary phytoestrogens and postmenopausal breast cancer risk.
    den Tonkelaar I; Keinan-Boker L; Veer PV; Arts CJ; Adlercreutz H; Thijssen JH; Peeters PH
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):223-8. PubMed ID: 11303591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cadmium exposure and breast cancer risk.
    McElroy JA; Shafer MM; Trentham-Dietz A; Hampton JM; Newcomb PA
    J Natl Cancer Inst; 2006 Jun; 98(12):869-73. PubMed ID: 16788160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified effect of urinary cadmium on breast cancer risk by selenium.
    Wei XL; He JR; Cen YL; Su Y; Chen LJ; Lin Y; Wu BH; Su FX; Tang LY; Ren ZF
    Clin Chim Acta; 2015 Jan; 438():80-5. PubMed ID: 25149105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai.
    Dai Q; Franke AA; Jin F; Shu XO; Hebert JR; Custer LJ; Cheng J; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):815-21. PubMed ID: 12223424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association between urinary cadmium and clinicopathological characteristics of breast cancer].
    Cen YL; Tang LY; Lin Y; Su FX; Wu BH; Ren ZF
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):632-5. PubMed ID: 24314225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary melatonin levels and breast cancer risk.
    Schernhammer ES; Hankinson SE
    J Natl Cancer Inst; 2005 Jul; 97(14):1084-7. PubMed ID: 16030307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
    Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
    Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary estrogen metabolites and breast cancer: a case-control study.
    Kabat GC; Chang CJ; Sparano JA; Sepkovie DW; Hu XP; Khalil A; Rosenblatt R; Bradlow HL
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):505-9. PubMed ID: 9232337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factors and breast cancer risk in Chinese women.
    Yu H; Jin F; Shu XO; Li BD; Dai Q; Cheng JR; Berkel HJ; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):705-12. PubMed ID: 12163322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipocytokine resistin and breast cancer risk.
    Sun CA; Wu MH; Chu CH; Chou YC; Hsu GC; Yang T; Chou WY; Yu CP; Yu JC
    Breast Cancer Res Treat; 2010 Oct; 123(3):869-76. PubMed ID: 20177966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homocysteine as a metabolic risk factor for breast cancer: findings from a case-control study in Taiwan.
    Chou YC; Lee MS; Wu MH; Shih HL; Yang T; Yu CP; Yu JC; Sun CA
    Breast Cancer Res Treat; 2007 Jan; 101(2):199-205. PubMed ID: 16850249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women.
    Shu XO; Jin F; Dai Q; Wen W; Potter JD; Kushi LH; Ruan Z; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):483-8. PubMed ID: 11352858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of plasma total cysteine and risk of breast cancer.
    Zhang SM; Willett WC; Selhub J; Manson JE; Colditz GA; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1188-93. PubMed ID: 14652279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between selenium and breast cancer: a case-control study in the Klang Valley.
    Suzana S; Cham BG; Ahmad Rohi G; Mohd Rizal R; Fairulnizal MN; Normah H; Fatimah A
    Singapore Med J; 2009 Mar; 50(3):265-9. PubMed ID: 19352569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.